Q2 EPS Forecast for Revolution Medicines Cut by Analyst
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Stock analysts at Wedbush decreased their Q2 2025 earnings per share estimates for shares of Revolution Medicines in a note issued to investors on Thursday, May 8th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($1.17) for the quarter, down […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Stock analysts at Wedbush decreased their Q2 2025 earnings per share estimates for shares of Revolution Medicines in a note issued to investors on Thursday, May 8th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($1.17) for the quarter, down […]
